Related Experiment Videos
Side effects associated with pneumococcal vaccination
K L Nichol1, R MacDonald, M Hauge
1Medical Service, VA Medical Center, Minneapolis, MN 55417, USA.
American Journal of Infection Control
|June 1, 1997
Summary
Pneumococcal vaccination is safe for older adults, with no increase in systemic side effects. Mild local reactions occurred in about a quarter of recipients, addressing a key barrier to immunization.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Pneumococcal disease poses a significant health risk, particularly for the elderly and high-risk populations.
- Despite recommendations, pneumococcal vaccination rates remain low, with underuse attributed to concerns about side effects.
- Addressing vaccine hesitancy is crucial for improving public health outcomes.
Purpose of the Study:
- To evaluate the safety of pneumococcal vaccination by assessing systemic and local side effects.
- To provide data that can help overcome barriers to pneumococcal immunization.
Main Methods:
- A survey of 1006 individuals attending a vaccination clinic was conducted.
- Participants were interviewed about their health and experienced symptoms during the week after vaccination.
- Reported symptoms were compared to a baseline period prior to vaccination.
Main Results:
- No increase in systemic symptoms (fever, rash, myalgias, fatigue, malaise, headache) was observed post-vaccination.
- Local reactions, such as injection site discomfort, occurred in 28.2% of recipients.
- Over 90% of local reactions were mild to moderate and did not significantly impair arm use.
Conclusions:
- Pneumococcal vaccination is not associated with an increase in systemic symptoms.
- Mild to moderate local symptoms are common in a subset of vaccine recipients.
- These findings can help alleviate patient concerns and improve vaccination uptake.